These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21368680)

  • 1. Use of patient-reported outcomes in randomized, double-blind, placebo-controlled clinical trials.
    Dinan MA; Compton KL; Dhillon JK; Hammill BG; Dewitt EM; Weinfurt KP; Schulman KA
    Med Care; 2011 Apr; 49(4):415-9. PubMed ID: 21368680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
    Brettschneider C; Lühmann D; Raspe H
    GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Patient-Reported Outcome Measurements in Adult Tumor Clinical Trials in China: Cross-Sectional Study.
    Jia Y; Li Q; Zhang X; Yan Y; Yan S; Li S; Li W; Wu X; Rong H; Liu J
    J Med Internet Res; 2024 May; 26():e45719. PubMed ID: 38718388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported outcomes in clinical trials of inhaled asthma medications: systematic review and research needs.
    Frampton GK; Shepherd J
    Qual Life Res; 2011 Apr; 20(3):343-57. PubMed ID: 20945162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communicating the results of randomized clinical trials: do patients understand multidimensional patient-reported outcomes?
    McNair AG; Brookes ST; Davis CR; Argyropoulos M; Blazeby JM
    J Clin Oncol; 2010 Feb; 28(5):738-43. PubMed ID: 20065187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive review of statistical methods for analysing patient-reported outcomes (PROs) used as primary outcomes in randomised controlled trials (RCTs) published by the UK's
    Qian Y; Walters SJ; Jacques R; Flight L
    BMJ Open; 2021 Sep; 11(9):e051673. PubMed ID: 34489292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of clinical and patient-reported outcomes in surgical oncology.
    Macefield RC; Avery KN; Blazeby JM
    Br J Surg; 2013 Jan; 100(1):28-37. PubMed ID: 23165422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of patient-reported outcomes in advanced breast cancer clinical trials: a review of the published literature.
    Turner-Bowker DM; Hao Y; Foley C; Galipeau N; Mazar I; Krohe M; Globe D; Shields AL
    Curr Med Res Opin; 2016 Oct; 32(10):1709-17. PubMed ID: 27331272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Reported Outcomes for Cancer Patients Receiving Checkpoint Inhibitors: Opportunities for Palliative Care-A Systematic Review.
    Hall ET; Singhal S; Dickerson J; Gabster B; Wong HN; Aslakson RA; Schapira L;
    J Pain Symptom Manage; 2019 Jul; 58(1):137-156.e1. PubMed ID: 30905677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare use of patient-reported outcomes in childhood cancer clinical trials - a systematic review of clinical trial registries.
    Riedl D; Rothmund M; Darlington AS; Sodergren S; Crazzolara R; de Rojas T;
    Eur J Cancer; 2021 Jul; 152():90-99. PubMed ID: 34090144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing the patient voice in prostate cancer research: Systematic review on the use of patient-reported outcomes in randomized controlled trials to support clinical decision-making.
    Van Hemelrijck M; Sparano F; Moris L; Beyer K; Cottone F; Sprangers M; Efficace F
    Cancer Med; 2020 Jun; 9(12):4039-4058. PubMed ID: 32333639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity.
    Colagiuri B
    Clin Trials; 2010 Jun; 7(3):246-55. PubMed ID: 20421243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported outcome (PRO) instruments used in patients undergoing adoptive cell therapy (ACT) for the treatment of cancer: a systematic review.
    Taylor S; Law K; Coomber-Moore J; Davies M; Thistlethwaite F; Calvert M; Aiyegbusi O; Yorke J
    Syst Rev; 2023 Sep; 12(1):183. PubMed ID: 37777816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion of older patients with cancer in randomised controlled trials with patient-reported outcomes: a systematic review.
    Sparano F; Aaronson NK; Sprangers MAG; Fayers P; Pusic A; Kieffer JM; Cottone F; Rees J; Pezold M; Anota A; Charton E; Vignetti M; Wan C; Blazeby J; Efficace F
    BMJ Support Palliat Care; 2019 Dec; 9(4):451-463. PubMed ID: 31719051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported Outcomes (PROs) in clinical trials in paediatric dentistry.
    Gilchrist F; Marshman Z
    Int J Paediatr Dent; 2020 Dec; 31 Suppl 1():31-37. PubMed ID: 33458920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life.
    Wiklund I
    Fundam Clin Pharmacol; 2004 Jun; 18(3):351-63. PubMed ID: 15147288
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.